Tyra Biosciences, Inc. Common Stock (TYRA)
PHARMACEUTICAL PREPARATIONS
Tyra Biosciences, Inc. Common Stock (TYRA) is listed on Nasdaq, where it has traded since September 15, 2021.
- Listed On
- Nasdaq
- Listed Since
- September 15, 2021
- Employees
- 87
- Market Cap
- $1.4B
About Tyra Biosciences, Inc. Common Stock
Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.
Institutional ownership
In 13F filings for the quarter ended September 30, 2026, 3 institutions reported holding TYRA, with 1,346 shares worth $29,437 in aggregate. The largest reported holder was Versant Capital Management, with 819 shares worth $17,912. Of the 3 largest holders listed below, 1 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Versant Capital Management | 819 | $18K | Unchanged |
| Gamma Investing | 452 | $10K | Reduced 10.5% |
| Farther Finance Advisors | 75 | $2K | Added 25% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is TYRA?
Tyra Biosciences, Inc. Common Stock (TYRA) is listed on Nasdaq, where it has traded since September 15, 2021.
Who are the largest institutional holders of TYRA?
In 13F filings for the quarter ended September 30, 2026, the largest reported holders of TYRA were Versant Capital Management, Gamma Investing and Farther Finance Advisors.
How many institutions own TYRA?
3 institutions reported a position in TYRA for the quarter ended September 30, 2026, worth $29,437 in total.
Did institutions buy or sell TYRA last quarter?
Of the 3 largest reported holders, 1 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for TYRA.
Every reported institutional holder, plus insider and congressional trades in TYRA, on SentiSense.